FreeTheAI

XORTX Therapeutics, Inc.

XRTX · NASDAQ · USD

$1.85

+0.105 6.02%todayNot financial advice.

XRTX Price chart 1Y
Open
1.75
Day range
1.72 - 1.90
52-week range
1.59 - 7.05
Volume
10.67M
Market cap
3.36M
P/E ratio
—
EPS
-2.74
Dividend yield
0.00%
Beta
0.51

Performance

W

+9.47%

1M

−15.67%

3M

−12.11%

6M

−17.78%

YTD

−34.99%

Y

−58.84%

5Y

−98.79%

All

−98.79%

In the news

  1. Oct 8

    XORTX Therapeutics Outlines Plan to File Canadian Clinical Trial Application for Gout Drug XORLO

    XORTX Therapeutics plans to submit a Clinical Trial Application in Canada for its gout treatment XORLO to accelerate its regulatory pathway to the FDA.

    Company news

  2. Oct 8

    XORTX Therapeutics Plans Clinical Trial Application in Canada for Gout Drug XORLO

    XORTX Therapeutics plans to file a clinical trial application in Canada for its gout treatment XORLO to accelerate its planned FDA approval pathway.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-XRTX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="XORTX Therapeutics, Inc. (XRTX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-XRTX">XRTX stock price</a> by FreeTheAI Stocks</p>